Seguir
LISA A. CAREY MD, ScM, FASCO
LISA A. CAREY MD, ScM, FASCO
University of North Carolina Lineberger Comprehensive Cancer Center
Dirección de correo verificada de med.unc.edu
Título
Citado por
Citado por
Año
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
LA Carey, CM Perou, CA Livasy, LG Dressler, D Cowan, K Conway, ...
Jama 295 (21), 2492-2502, 2006
49782006
The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes
LA Carey, EC Dees, L Sawyer, L Gatti, DT Moore, F Collichio, DW Ollila, ...
Clinical cancer research 13 (8), 2329-2334, 2007
27812007
The molecular portraits of breast tumors are conserved across microarray platforms
Z Hu, C Fan, DS Oh, JS Marron, X He, BF Qaqish, C Livasy, LA Carey, ...
BMC genomics 7, 1-12, 2006
18632006
Molecular classification and molecular forecasting of breast cancer: ready for clinical application?
J Brenton, LA Carey, AA Ahmed, C Caldas
Journal of clinical oncology 23 (29), 7350-7360, 2005
13152005
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
G Curigliano, HJ Burstein, EP Winer, M Gnant, P Dubsky, S Loibl, ...
Annals of Oncology 28 (8), 1700-1712, 2017
12242017
4th ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 4)
F Cardoso, E Senkus, A Costa, E Papadopoulos, M Aapro, F André, ...
Annals of Oncology 29 (8), 1634-1657, 2018
12182018
Epidemiology of basal-like breast cancer
RC Millikan, B Newman, CK Tse, PG Moorman, K Conway, LV Smith, ...
Breast cancer research and treatment 109, 123-139, 2008
11862008
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete …
WM Sikov, DA Berry, CM Perou, B Singh, CT Cirrincione, SM Tolaney, ...
Journal of clinical oncology 33 (1), 13, 2015
11322015
Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer
RK Murthy, S Loi, A Okines, E Paplomata, E Hamilton, SA Hurvitz, NU Lin, ...
New England Journal of Medicine 382 (7), 597-609, 2020
10342020
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
F Cardoso, S Paluch-Shimon, E Senkus, G Curigliano, MS Aapro, F André, ...
Annals of Oncology 31 (12), 1623-1649, 2020
9962020
Triple-negative breast cancer: disease entity or title of convenience?
L Carey, E Winer, G Viale, D Cameron, L Gianni
Nature reviews Clinical oncology 7 (12), 683-692, 2010
9552010
Phase III randomized study of ribociclib and fulvestrant in hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer: MONALEESA-3
DJ Slamon, P Neven, S Chia, PA Fasching, M De Laurentiis, SA Im, ...
Journal of Clinical Oncology 36 (24), 2465-2472, 2018
9322018
3rd ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 3)
F Cardoso, A Costa, E Senkus, M Aapro, F André, CH Barrios, J Bergh, ...
The Breast 31, 244-259, 2017
8712017
Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer
CK Anders, LA Carey
Clinical breast cancer 9, S73-S81, 2009
8522009
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer
SM Tolaney, WT Barry, CT Dang, DA Yardley, B Moy, PK Marcom, ...
New England Journal of Medicine 372 (2), 134-141, 2015
8502015
Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP guideline update.
KH Allison, MEH Hammond, M Dowsett, SE McKernin, LA Carey, ...
8432020
Phase II trial of bicalutamide in patients with androgen receptor–positive, estrogen receptor–negative metastatic breast cancer
A Gucalp, S Tolaney, SJ Isakoff, JN Ingle, MC Liu, LA Carey, K Blackwell, ...
Clinical cancer research 19 (19), 5505-5512, 2013
8142013
Sacituzumab govitecan in metastatic triple-negative breast cancer
A Bardia, SA Hurvitz, SM Tolaney, D Loirat, K Punie, M Oliveira, A Brufsky, ...
New England journal of medicine 384 (16), 1529-1541, 2021
8052021
Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals
A Flanagin, LA Carey, PB Fontanarosa, SG Phillips, BP Pace, ...
Jama 280 (3), 222-224, 1998
7341998
Molecular characterization of basal‐like and non‐basal‐like triple‐negative breast cancer
A Prat, B Adamo, MCU Cheang, CK Anders, LA Carey, CM Perou
The oncologist 18 (2), 123-133, 2013
7122013
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20